Kintara Therapeutics:On June 4,Co Submitted Request to Nasdaq for Additional 180-Day Extension to Regain Compliance With Minimum Bid Price Requirement
Kintara Therapeutics:6月4日,公司向納斯達克提交請求,申請額外的180天延期以符合最低買盤要求。
Kintara Therapeutics:On June 4,Co Submitted Request to Nasdaq for Additional 180-Day Extension to Regain Compliance With Minimum Bid Price Requirement
Kintara Therapeutics:6月4日,公司向納斯達克提交請求,申請額外的180天延期以符合最低買盤要求。
譯文內容由第三人軟體翻譯。